41) Quest Report Status: Partial EPSTEIN, JEFFREY CLIENT SERVICES: 866.697.8378 SPECIMEN: NIR0° I0I2M Quest. Quest Diagnostics. the associated logo and all associated Quest Diagnostics marks arc the trademarks orQuest Diagnostics. Patient Information Specimen Information Client Information EPSTEIN, JEFFREY DOB: 01/20/1953 ACE: 62 Gender: ii Phone: Patient II Health I Specimen: MR00I01214 Requisition: 0018435 Collected: 08/24/2015 Received: 08/24/2015 / 19:39 EDT Reported: 08/25/2015 / 12:45 EDT Client #: MOSKOWITZ, BRUCE W UCA/MOSKOWITZ BRUCE MD Attn: **1) GRJUNIV.CLINICAL 1411 N FLAGLER DR STE 7100 WEST PALM BEACH, FL 33401 Test Name LIPID PANEL CHOLESTEROL, TOTAL HDL CHOLESTEROL TRIGLYCERIDES LDL-CHOLESTEROL In Range Out Of Range 212 H 25 L 673 H LDL cholesterol not calculated. Triglyceride levels greater than 400 mg/dL invalidate calculated LDL results. Desirable range <100 mg/dL for patients with CHD or diabetes and <70 mg/dL for diabetic patients with known heart disease. CHOL/HDLC RATIO 8.5 H NON HDL CHOLESTEROL 187 H Target for non-HDL cholesterol is 30 mg/dL higher than LDL cholesterol target. HS CRP 1.0 Reference Range 125-200 mg/dL > OR = 40 mg/dL <150 mg/dL <130 mg/dL (calc) < OR = 5.0 (calc) mg/dL (calc) mg/L The above test was performed; the specimen was lipemic. Average relative cardiovascular risk according to AHA/CDC guidelines. For ages >17 hs-CRP mg/L <1.0 1.0-3.0 3.1-10.0 >10.0 Years: Risk According to AHA/CDC Guidelines Lower relative cardiovascular risk. Average relative cardiovascular risk. Higher relative cardiovascular risk. Consider retesting in 1 to 2 weeks to exclude a benign transient elevation in the baseline CRP value secondary to infection or inflammation. Persistent elevation, upon retesting, may be associated with infection and inflammation. however, Lab MI MI MI MI MI MI MI HOMOCYSTEINE 15.7 H <11.4 umol/L MI Homocysteine is increased by functional deficiency of folate or vitamin 812. Testing for methylmalonic acid differentiates between these deficiencies. Other causes of increased homocysteine include renal failure, folate antagonists such as methotrexate and phenytoin, and exposure to nitrous oxide. COMPREHENSIVE METABOLIC MI PANEL GLUCOSE 118 H 65-99 mg/dL Fasting reference interval PAGE1OF3 EFTA_R1_00901591 EFTA02196925 4111Quest • :.: fly, : Report Status: Partial EPSTEIN, JEFFREY Patient Information Specimen Information Client Information EPSTEIN, JEFFREY Specimen: MR001012M Client 4: Collected: 08/24/2015 MOSKOil l, RU DOB: 01/20/1953 ACE: 62 Received: 08/24/2015 / 19:39 EDT Gender: M Reported: 08/25/2015 / 12:45 EDT Patient ID: Health ID: Test Name In Range Out Of Range UREA NITROGEN (BUN) 18 CREATININE 1.09 For patients >49 years of age, the reference limit for Creatinine is approximately 13% higher for people identified as African -American. eGFR NON-AFR. AMERICAN eGFR AFRICAN AMERICAN BUN/CREATININE RATIO SODIUM POTASSIUM CHLORIDE CARBON DIOXIDE CALCIUM PROTEIN, TOTAL ALBUMIN GLOBULIN ALBUMIN/GLOBULIN RATIO BILIRUBIN, TOTAL ALKALINE PHOSPHATASE AST ALT URIC ACID Therapeutic target for gout 72 84 NOT APPLICABLE 139 4.2 108 25 9.8 7.3 4.5 2.8 1.6 0.7 64 16 21 8.0 patients: <6.0 mg/dL TSH 2.29 T4 (THYROXINE), TOTAL 7.2 FREE T4 INDEX (T7) 2.2 T3 UPTAKE 30 SED RATE BY MODIFIED WESTERGREN 6 CBC (INCLUDES DIFF/PLT) WHITE BLOOD CELL COUNT 6.3 RED BLOOD CELL COUNT 5.17 HEMOGLOBIN 15.1 HEMATOCRIT 44.3 MCV 85.8 MCH 29.1 MCHC 33.9 RDW 14.3 PLATELET COUNT 262 MPV 7.5 ABSOLUTE NEUTROPHILS 3314 ABSOLUTE LYMPHOCYTES 2205 ABSOLUTE MONOCYTES 428 ABSOLUTE EOSINOPHILS 315 ABSOLUTE BASOPHILS 38 NEUTROPHILS 52.6 LYMPHOCYTES 35.0 MONOCYTES 6.8 EOSINOPHILS 5.0 BASOPHILS 0.6 URINALYSIS, COMPLETE COLOR APPEARANCE CLIENT SERVICES: 866.697.8378 YELLOW CLEAR SPECUNEN:NIROOIOI2M Reference Range 7-25 mg/dL 0.70-1.25 mg/dL > OR - 60 mL/min/1.73m2 > OR = 60 mL/min/1.73m2 6-22 (calc) 135-146 mmol/L 3.5-5.3 mmol/L 98-110 mmol/L 19-30 mmol/L 8.6-10.3 mg/dL 6.1-8.1 g/dL 3.6-5.1 g/dL 1.9-3.7 g/dL (calc) 1.0-2.5 (calc) 0.2-1.2 mg/dL 40-115 U/L 10-35 U/L 9-46 U/L 4.0-8.0 mg/dL 0.40-4.50 mIU/L 4.5-12.0 mcg/dL 1.4-3.8 22-35 % < OR = 20 mm/h 3.8-10.8 Thousand/uL 4.20-5.80 Million/uL 13.2-17.1 g/dL 38.5-50.0 % 80.0-100.0 fL 27.0-33.0 pg 32.0-36.0 g/dL 11.0-15.0 % 140-400 Thousand/uL 7.5-11.5 fL 1500-7800 cells/uL 850-3900 cells/uL 200-950 cells/uL 15-500 cells/uL 0-200 cells/uL YELLOW CLEAR Quest. Quest Diagnostics. the associated logo and all associated Quest Diagnostics marks are the trademarks orQuest Diagnostics. Lab MI MI MI MI MI MI MI PAGE20F3 EFTA_R1_00901592 EFTA02196926 4111Quest • fly. : Report Status: Partial EPSTEIN, JEFFREY Patient Information Specimen Information Client Information EPSTEIN, JEFFREY DOB: 01/20/1953 ACE: 62 Gender: M Patient ID: 090443348 Health ID: 8573003290851249 Specimen: MR001012M Collected: 08/24/2015 Received: 08/24/2015 / 19:39 EDT Reported: 08/25/2015 / 12:45 EDT Client #: MOSKOWITZ, BRUCE W Teat Name SPECIFIC GRAVITY PH GLUCOSE BILIRUBIN KETONES OCCULT BLOOD PROTEIN NITRITE LEUKOCYTE ESTERASE wag RBC SQUAMOUS EPITHELIAL CELLS BACTERIA HYALINE CAST C-REACTIVE PROTEIN <0.80 mgidL Please be advised that patients •t aking Carboxypenicillins may exhibit falsely decreased C-Reactive Protein levels due to an analytical interference in this assay. PROLACTIN 3.2 2.0-18.0 ng/mL TESTOSTERONE, TOTAL, MALES (ADULT), IA 129 L 250-827 ng/dL Men with clinically significant hypogonadal symptoms and testosterone values repeatedly less than 300 ng/dL may benefit from testosterone treatment after adequate risk and benefits counseling. In hypogonadal males, Testosterone, Total, LC/MS/MS, is the recommended assay due to the diminished accuracy of immunoassay at levels below 250 ng/dL. This test code (15983) must be collected in a red-top tube with no gel. Two morning (8-10 a.m.) specimens obtained on different days are recommended by The Endocrine Society for screening for hypogonadism. PSA, TOTAL 0.6 In Range 1.022 5.5 NEGATIVE NEGATIVE NEGATIVE NEGATIVE NEGATIVE NEGATIVE NEGATIVE NONE SEEN NONE SEEN NONE SEEN NONE SEEN NONE SEEN Out Of Range Reference Range 1.001-1.035 5.0-8.0 NEGATIVE NEGATIVE NEGATIVE NEGATIVE NEGATIVE NEGATIVE NEGATIVE < OR - 5 /HPF < OR - 2 /HPF < OR = 5 /HPF NONE SEEN /HPF NONE SEEN /LPF This test was performed using the Siemens chemiluminescent method. Values obtained from different assay methods cannot be used interchangeably. PSA levels, regardless of value, should not be interpreted as absolute evidence of the presence or absence of disease. PENDING TESTS: Lab MI MI MI < OR 4.0 ng/mL MI IILMOOLOBIN Ale CULTURE, URINE, ROUTINE VITAMIN BI2 PERFORMING SITE: MI QUEST DIAGNOSTICS -MIAMI. I 0200 COMMERCE PARKWAY. MIRAMAR. FL 33025-3938 Laboroxy Dustier GLDI L DORM MD PHD. CLJA: 10530277334 CLIENT SERVICES: 866.697.8378 SPECINIEN:N4R001012M Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks orQuest Diagnostics. PAGE3OF3 EFTA_R1_00901593 EFTA02196927